In this study, we focus on four proteins that play crucial roles in the context of lung cancer: human cyclin-dependent kinase-2 (CDK2), SRC-2 domains of C-ABL, epidermal growth factor (EGF), and insulin-like growth factor-1 receptor kinase (IGF-1R). This evidence concerns the gene CDK2 and lung carcinoma.